Preclinical validation of oxytocin as a novel treatment for alcohol dependence

Funding Activity

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Alcohol dependence is a major cause of mental and physical illness in Australia. Current medications for treating this condition are of limited effectiveness. This project will investigate the ability of the hormone oxytocin to reduce alcohol abuse and alcohol craving and to reverse the brain damage that alcohol causes. The project will also develop new medications, based on oxytocin, but with more powerful and longer lasting effects. These medications may provide a breakthrough in the fight against alcoholism.

Funded Activity Details

Start Date: 01-01-2011

End Date: 01-01-2013

Funding Scheme: NHMRC Project Grants

Funding Amount: $517,624.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Basic Pharmacology

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

addiction | alcohol abuse | anxiety | brain function | c-Fos | drug discovery | neuropeptides | oxytocin | relapse | substance use